United Services Automobile Association’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-4,287
Closed -$404K 1893
2019
Q2
$404K Sell
4,287
-170
-4% -$14.7K ﹤0.01% 1719
2019
Q1
$381K Sell
4,457
-15
-0.3% -$1.25K ﹤0.01% 1766
2018
Q4
$251K Buy
4,472
+1,283
+40% +$78.3K ﹤0.01% 1911
2018
Q3
$261K Buy
+3,189
New +$225K ﹤0.01% 2000

Other funds holding RETA

United Services Automobile Association's RETA Position: Q3 2019 in Review

United Services Automobile Association sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2019, closing a stake of 4,287 shares — an estimated $404K sold.

United Services Automobile Association first reported a position in RETA in Q3 2018 and held it in 4 quarters. The position peaked at $404K in Q2 2019. 164 funds tracked by Wall St. Rank hold RETA as of Q3 2019.

  • United Services Automobile Association reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2019 after selling out during the quarter.
  • United Services Automobile Association sold 4,287 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2019, an estimated $404K.
  • United Services Automobile Association first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2018 and held it in 4 quarters.
  • United Services Automobile Association's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $404K in Q2 2019.
  • 164 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2019.

Based on United Services Automobile Association's 13F filing for Q3 2019, filed 13 Nov 2019.